1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Hemangiomas Global Clinical Trials Review, H1, 2014

Hemangiomas Global Clinical Trials Review, H1, 2014

  • February 2014
  • -
  • Global Data
  • -
  • 76 pages

Hemangiomas Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Hemangiomas Global Clinical Trials Review, H1, 2014" provides data on the Hemangiomas clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hemangiomas. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hemangiomas. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Hemangiomas Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Hemangiomas 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Hemangiomas to Dermatology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Hemangiomas to Dermatology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Hemangiomas 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Hemangiomas Therapeutics Clinical Trials 30
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Laboratoires Pierre Fabre SA 32
Clinical Trial Overview of Laboratoires Pierre Fabre SA 32
MethylGene Inc. 33
Clinical Trial Overview of MethylGene Inc. 33
Maruho Co., Ltd. 34
Clinical Trial Overview of Maruho Co., Ltd. 34
InfectoPharm Arzneimittel und Consilium GmbH 35
Clinical Trial Overview of InfectoPharm Arzneimittel und Consilium GmbH 35
Clinical Trial Overview of Top Institutes / Government 36
Medical College of Wisconsin 36
Clinical Trial Overview of Medical College of Wisconsin 36
The University of New Mexico 37
Clinical Trial Overview of The University of New Mexico 37
The Hospital for Sick Children 38
Clinical Trial Overview of The Hospital for Sick Children 38
Keio University 39
Clinical Trial Overview of Keio University 39
The Ohio State University 40
Clinical Trial Overview of The Ohio State University 40
Southwest Hospital, China 41
Clinical Trial Overview of Southwest Hospital, China 41
Oregon Health and Science University 42
Clinical Trial Overview of Oregon Health and Science University 42
National Institute of Neurological Disorders and Stroke 43
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 43
Eastern Hepatobiliary Surgery Hospital 44
Clinical Trial Overview of Eastern Hepatobiliary Surgery Hospital 44
National Cancer Institute 45
Clinical Trial Overview of National Cancer Institute 45
Five Key Clinical Profiles 46
Appendix 74
Abbreviations 74
Definitions 74
Research Methodology 75
Secondary Research 75
About GlobalData 76
Contact Us 76
Disclaimer 76
Source 76

List of Tables
Hemangiomas Therapeutics, Global, Clinical Trials by Region, 2014* 7
Hemangiomas Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Hemangiomas Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Hemangiomas Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Hemangiomas Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Hemangiomas Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Hemangiomas Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Hemangiomas Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Hemangiomas to Dermatology Clinical Trials, G7 Countries (%), 2014* 15
Hemangiomas Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Hemangiomas Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Hemangiomas to Dermatology Clinical Trials, E7 Countries (%), 2014* 18
Hemangiomas Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Hemangiomas Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Hemangiomas Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Hemangiomas Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Hemangiomas Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Hemangiomas Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Hemangiomas Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Hemangiomas Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Hemangiomas Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Hemangiomas Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28
Hemangiomas Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Hemangiomas Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Hemangiomas Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
Hemangiomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratoires Pierre Fabre SA, 2014* 32
Hemangiomas Therapeutics Clinical Trials Market, Global, Clinical Trials by MethylGene Inc., 2014* 33
Hemangiomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Maruho Co., Ltd., 2014* 34
Hemangiomas Therapeutics Clinical Trials Market, Global, Clinical Trials by InfectoPharm Arzneimittel und Consilium GmbH, 2014* 35
Hemangiomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical College of Wisconsin, 2014* 36
Hemangiomas Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of New Mexico, 2014* 37
Hemangiomas Therapeutics Clinical Trials Market, Global, Clinical Trials by The Hospital for Sick Children, 2014* 38
Hemangiomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Keio University, 2014* 39
Hemangiomas Therapeutics Clinical Trials Market, Global, Clinical Trials by The Ohio State University, 2014* 40
Hemangiomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Southwest Hospital, China, 2014* 41
Hemangiomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Oregon Health and Science University, 2014* 42
Hemangiomas Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2014* 43
Hemangiomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Eastern Hepatobiliary Surgery Hospital, 2014* 44
Hemangiomas Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 45

List of Figures
Hemangiomas Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Hemangiomas Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Hemangiomas Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Hemangiomas Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Hemangiomas Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Hemangiomas Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Hemangiomas Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Hemangiomas to Dermatology Clinical Trials, G7 Countries (%), 2014* 15
Hemangiomas Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Hemangiomas Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Hemangiomas to Dermatology Clinical Trials, E7 Countries (%), 2014* 18
Hemangiomas Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Hemangiomas Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Hemangiomas Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Hemangiomas Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Hemangiomas Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Hemangiomas Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Hemangiomas Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 28
Hemangiomas Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Hemangiomas Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Hemangiomas Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
GlobalData Methodology 75

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.